Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

ACADACAD
31 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in ACADIA PHARMACEUTICALS INC

CITADEL ADVISORS LLC holds 2.2M shares of ACAD (ACADIA PHARMACEUTICALS INC), worth $55.2M as of 2026-Q2. The position was increased (+250.4% shares). ACAD represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$55.2M

Current Shares

2.2M

Total Value Change

+$9.3M

Total Shares Change

-656,745

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.2M
+250.4%
$55.2M0.0%$25.30
47
2026-Q1
Decreased
622,760
-54.5%
$13.9M0.0%$22.50
0
2025-Q4
Increased
1.4M
+322.7%
$36.5M0.0%$26.70
47
2025-Q3
Decreased
323,520
-89.3%
$6.9M0.0%$21.32
0
2025-Q2
Increased
3M
+922.4%
$65M0.0%$22.12
48
2025-Q1
Decreased
294,660
-12.8%
$4.9M0.0%$17.07
0
2024-Q4
Increased
337,865
+101.6%
$6.2M0.0%$16.69
44
2024-Q3
Decreased
167,562
-74.4%
$2.6M0.0%$15.69
0
2024-Q2
Increased
653,768
+14.8%
$10.6M0.0%$16.25
32
2024-Q1
Increased
569,258
+272.0%
$10.5M0.0%$18.49
45
2023-Q4
Increased
153,034
+2729.3%
$4.8M0.0%$31.31
43
2023-Q3
Decreased
5,409
-76.7%
$112,7240.0%$20.84
0
2023-Q2
Decreased
23,201
-77.6%
$555,6640.0%$24.00
0
2023-Q1
Decreased
103,683
-52.8%
$2M0.0%$18.70
0
2022-Q4
Decreased
219,758
-46.3%
$3.5M0.0%$15.92
0
2022-Q3
Increased
409,279
+36.8%
$6.7M0.0%$16.14
36
2022-Q2
Decreased
299,297
-28.2%
$4.2M0.0%$14.22
0
2022-Q1
Increased
416,938
+74.7%
$10.1M0.0%$24.41
42
2021-Q4
Decreased
238,675
-69.6%
$5.6M0.0%$23.54
0
2021-Q3
Increased
784,091
+485.1%
$13M0.0%$16.96
45
2021-Q2
Decreased
134,006
-41.5%
$3.3M0.0%$24.13
0
2021-Q1
Decreased
229,054
-82.0%
$5.9M0.0%$25.71
0
2020-Q4
Decreased
1.3M
-50.5%
$68.1M0.0%$53.69
0
2020-Q3
Decreased
2.6M
-33.5%
$106M0.0%$40.41
0
2020-Q2
Increased
3.9M
+4.5%
$187.4M0.1%$48.16
32
2020-Q1
Increased
3.7M
+41.0%
$156.4M0.1%$41.32
40
2019-Q4
Increased
2.6M
+37.1%
$112.3M0.0%$43.16
39
2019-Q3
Increased
1.9M
+8.6%
$68.9M0.0%$36.78
32
2019-Q2
Decreased
1.8M
-0.7%
$47.1M0.0%$26.73
0
2019-Q1
Decreased
1.8M
-37.4%
$47.7M0.0%$26.85
0
2018-Q4
New
2.8M
-
$45.9M0.0%$15.65
40

Other major holders of ACAD: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used